This invention provides cyclic polypeptide compounds and their uses, specifically disclosing cyclic polypeptide
compound A and cyclic polypeptide compound B. Cyclic polypeptide
compound A is a compound formed by chelating compound X with a therapeutic
radionuclide ion. Cyclic polypeptide compound B is a compound formed by chelating compound X with a diagnostic
radionuclide ion. These compounds can be used for the diagnosis and treatment of tumors associated with or mediated by FAP, exhibiting high tumor uptake, long
residence times, and broad applicability.
JPEG2026513316000414.jpg50104